+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Pulmonary Arterial Hypertension: 68-Market Analysis and Sales Forecast - Product Thumbnail Image

Pulmonary Arterial Hypertension: 68-Market Analysis and Sales Forecast

  • Report
  • June 2025
  • 15 Pages
  • Global
From
Pulmonary Arterial Hypertension: Seven-Market Drug Forecast and Market Analysis to 2034 - Product Thumbnail Image

Pulmonary Arterial Hypertension: Seven-Market Drug Forecast and Market Analysis to 2034

  • Report
  • June 2025
  • 106 Pages
  • Global
From
Respiratory Syncytial Virus (RSV) Infections - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Respiratory Syncytial Virus (RSV) Infections - Global Clinical Trials Review, 2025

  • Clinical Trials
  • June 2025
  • 281 Pages
  • Global
From
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) - Global Clinical Trials Review, 2025

  • Clinical Trials
  • June 2025
  • Global
From
Multiple Sclerosis - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Multiple Sclerosis - Global Clinical Trials Review, 2025

  • Clinical Trials
  • June 2025
  • Global
From
Multiple Sclerosis - Seven-Market Drug Forecast and Market Analysis - Product Thumbnail Image

Multiple Sclerosis - Seven-Market Drug Forecast and Market Analysis

  • Report
  • June 2025
  • 112 Pages
  • Global
From
Psoriatic Arthritis - Seven-Market Drug Forecast and Market Analysis - Product Thumbnail Image

Psoriatic Arthritis - Seven-Market Drug Forecast and Market Analysis

  • Report
  • June 2025
  • 101 Pages
  • Global
From
Nontuberculous Mycobacteria (NTM): Opportunity Assessment and Forecast - Product Thumbnail Image

Nontuberculous Mycobacteria (NTM): Opportunity Assessment and Forecast

  • Report
  • June 2025
  • 61 Pages
  • Global
From
Metabolic Dysfunction-Associated Steatohepatitis (MASH): Seven-Market Drug Forecast and Market Analysis - Update - Product Thumbnail Image

Metabolic Dysfunction-Associated Steatohepatitis (MASH): Seven-Market Drug Forecast and Market Analysis - Update

  • Report
  • June 2025
  • 131 Pages
  • Global
From
Myasthenia Gravis: Opportunity Assessment and Forecast - Product Thumbnail Image

Myasthenia Gravis: Opportunity Assessment and Forecast

  • Report
  • June 2025
  • 85 Pages
  • Global
From
Multiple Sclerosis: Epidemiology Forecast to 2034 - Product Thumbnail Image

Multiple Sclerosis: Epidemiology Forecast to 2034

  • Report
  • June 2025
  • 33 Pages
  • Global
From
Pulmonary Arterial Hypertension: Epidemiology Forecast to 2034 - Product Thumbnail Image

Pulmonary Arterial Hypertension: Epidemiology Forecast to 2034

  • Report
  • June 2025
  • 46 Pages
  • Global
From
Mucopolysaccharidosis II (Hunter Syndrome): Market View - Product Thumbnail Image

Mucopolysaccharidosis II (Hunter Syndrome): Market View

  • Report
  • May 2025
  • 80 Pages
  • Global
From
Human Immunodeficiency Virus (HIV): Seven-Market Drug Forecast and Market Analysis - Product Thumbnail Image

Human Immunodeficiency Virus (HIV): Seven-Market Drug Forecast and Market Analysis

  • Report
  • May 2025
  • 134 Pages
  • Global
From
Mucopolysaccharidosis III (Sanfilippo Syndrome):Market View - Product Thumbnail Image

Mucopolysaccharidosis III (Sanfilippo Syndrome):Market View

  • Report
  • May 2025
  • 71 Pages
  • Global
From
Hypoglycemia - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Hypoglycemia - Global Clinical Trials Review, 2025

  • Clinical Trials
  • May 2025
  • 252 Pages
  • Global
From
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Global Clinical Trials Review, 2025

  • Clinical Trials
  • May 2025
  • 104 Pages
  • Global
From
Migraine - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Migraine - Global Clinical Trials Review, 2025

  • Clinical Trials
  • May 2025
  • 1381 Pages
  • Global
From
Vertigo - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Vertigo - Global Clinical Trials Review, 2025

  • Clinical Trials
  • May 2025
  • 155 Pages
  • Global
From
Mucopolysaccharidosis I (MPS I) (Hurler syndrome): Market View - Product Thumbnail Image

Mucopolysaccharidosis I (MPS I) (Hurler syndrome): Market View

  • Report
  • May 2025
  • 76 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more